121 King Street, Melbourne [email protected]

biostarpharma8k021711 htm

biostarpharma8k021711 htm

biostarpharma8k021711.htm - SEC

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)